ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 62

Clinical Implication of Rheumatoid Factor Formation According to Various Hepatitis B Virus Infection Status and Vaccination

Sang Tae Choi1, Hyun Woong Lee2, Jung-Soo Song1, Soo Kon Lee3 and Yong-Beom Park4, 1Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, 2Hepatology, Chung-Ang University School of Medicine, Seoul, South Korea, 3Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea, 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: DNA, hepatitis and rheumatic disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid factor (RF) is produced as a result of polyclonal B cell activation, but the reasons for its production are still unknown. RF positivity can be seen in several diseases other than rheumatoid arthritis (RA), such as other rheumatic diseases and viral infection as well as in normal individuals. It was reported that RF was present in hepatitis B virus (HBV) infection. However, the types of antigens or antibodies of HBV and the hepatitis B viral load that play an important role in the development of RF remain obscure. In this study, we investigated the RF positive rates and titers of RF according to various HBV infection status and vaccination, and the relationship between the titers of RF and serum HBV DNA levels in HBV endemic areas.

Methods: The subjects were 13,670 individuals who visited the Severance Hospital Health Promotion Center in Seoul, Korea, for routine health check-up from January 2004 to December 2004. The samples were tested for RF (IgM type) and HBV infection by screening for the presence of HBsAg, anti-HBs (IgG type), and anti-HBc (IgG type). The HBeAg, anti-HBe (IgG type), and HBV DNA were analyzed in subjects positive for HBsAg. The RF positive rates and the titers of RF were evaluated based on the presence of each HBV viral marker, and correlation between the titers of RF and the serum HBV DNA levels was assessed.

Results: RF was positive in 3.5% of all subjects, and HBsAg was positive in 4.3%. HBsAg was positive in 21.7% of RF positive subjects. The HBsAg positive group had higher RF positive rate than negative group (17.5% vs 2.9%, p < 0.001). The RF positive rate was lower in those who had anti-HBs after HBV vaccination than in HBsAg positive subjects (2.7% vs 17.5%, p < 0.001). Among HBsAg positive subjects, the RF positive rate in the anti-HBs positive group was higher than that in the anti-HBs negative group (30.3% vs 16.8%, p = 0.047). However, there was no significant difference in the RF positive rate between the anti-HBc positive and negative groups, and HBeAg positive and negative groups. In multiple logistic regression analysis, the RF positive rate was increased in positive HBsAg (PR = 7.82, 95% CI 5.74 to 10.67, p < 0.001), female sex (PR = 1.21, 95% CI 1.01 to 1.46, p = 0.042) and older age (PR = 1.01, 95% CI 1.001 to 1.019, p = 0.027). Among the RF positive patients, the titer of RF in HBsAg positive patients were higher than those in HBsAg negative patients (159.7 ± 217.1 IU/mL vs 83.0 ± 179.2 IU/mL, p = 0.001). However, there were no significant differences in the titer of RF between anti-HBc positive and negative groups, and between HBeAg positive and negative groups. The load of HBV DNA may be closely correlated with the titer of RF in patients with chronic hepatitis B (r = 0.508, p = 0.005).

Conclusion: HBV infection is an important cause of the false positive RF in HBV endemic area. Especially hepatitis B viral load may be associated with the titer of RF. Therefore, HBV vaccination may decrease the risk of RF formation.


Disclosure:

S. T. Choi,
None;

H. W. Lee,
None;

J. S. Song,
None;

S. K. Lee,
None;

Y. B. Park,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-implication-of-rheumatoid-factor-formation-according-to-various-hepatitis-b-virus-infection-status-and-vaccination/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology